Reneo Pharmaceuticals Inc. Recorded Big Gain
Wed, Oct 09, 2024 at 07:28 PM
Reneo Pharmaceuticals Inc. (RPHM:NASDAQ) rocketted at $18.2, a gain of 952%. The stock appeared on our News Catalysts scanner on Mon, Oct 07, 2024 at 07:28 AM in the 'MERGER' category. From Wed, Sep 25, 2024, the stock recorded 70.00% Up Days and 81.82% Green Days
About Reneo Pharmaceuticals Inc. (RPHM:NASDAQ)
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- Momentus Inc. (MNTS:NASDAQ), 155.42%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 81.88%
- Lee Enterprises Incorporated (LEE:NASDAQ), 46.78%
- WW International, Inc. (WW:NASDAQ), 37.93%
- Kaixin Auto Holdings (KXIN:NASDAQ), 37.22%
- Surf Air Mobility Inc. (SRFM:NYSE), 30.9%
- Arcadium Lithium plc (ALTM:NYSE), 30.9%
- Mainz Biomed B.V. (MYNZ:NASDAQ), 29.76%
- Nuwellis Inc. (NUWE:NASDAQ), 29.27%